Keros is shifting toward rinvatercept-led neuromuscular development, with phase II plans, early human signals and cash runway shaping the KROS story.
Researchers at Tokushima University have demonstrated single-channel wireless transmission at 112 Gbps in the 560 GHz band ...
The race for 6G wireless data has just achieved a major speed limit. Japanese ...
A programmable metasurface stamps temporal codes onto ambient radio waves, enabling passive radar to detect and track drones ...
Artificial intelligence, precision medicine, RNA biology, and novel drug delivery technologies are rapidly reshaping how Wall Street evaluates emerging healthcare companies. As larger pharmaceutical ...
It's not too early to start planning for Wi-Fi 8. New features include non-primary channel access, seamless mobility domain ...
As competition in the weight loss drug market progressively intensifies, the latest Phase III clinical data disclosed by ...
Once wavelength approaches surface texture and absorption dominates link behavior, assumptions inherited from sub-6 GHz and ...
ReCode Therapeutics, a clinical-stage genetic medicines company using lipid nanoparticle delivery to power the next wave of mRNA and gene correction therapeutics, today announced the presentation of ...
Toshiba Electronic Devices & Storage Corporation (“Toshiba”) has started to ship engineering samples of "TB9M040FTG," a motor ...
Last month we discussed how all interconnects will be optical in the data center in five years, but that’s only part of the ...